Blood Flow Restriction Training in Acute Geriatric Rehabilitation
Recruiting
N/A
Interventional Study
Sarcopenia in Elderly
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- University Hospital, Bonn · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background: Older adults have a reduced ability to build and maintain muscle mass due to age-related changes in the muscular system. The resulting sarcopenia can lead to a number of health problems and limitations, such as an increased risk of falling and reduced mobility, which can affect quality of life and increase the risk of disease. To increase muscle mass and strength, high-intensity resist…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults \>65 years with a two week hospitalized acute rehabilitation after a fracture closed to the hip joint
Exclusion Criteria:
* Sickle Cell Anemia
* Iatrogenic changes of the vessels at the place of the tournqiuet application (e.g. Stents)
Contacts